Growth Metrics

Electromed (ELMD) Other Non-Current Liabilities (2018 - 2026)

Electromed (ELMD) reported Other Non-Current Liabilities of $81000.0 for Q1 2026, down 15.62% on a QoQ basis from $96000.0 in Q4 2025.

Electromed (ELMD) has 9 years of Other Non-Current Liabilities data on file, last reported at $81000.0 in Q1 2026.

  • Quarterly Other Non-Current Liabilities changed N/A year-over-year to $81000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81000.0 (changed N/A YoY) and the FY2025 annual result came in at $125000.0, up 941.67% from the prior year.
  • Other Non-Current Liabilities retreated to $81000.0 in Q1 2026 per ELMD's latest filing, from $96000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $125000.0 in Q2 2025 and bottomed at $4000.0 in Q4 2024.
  • The 5-year median for Other Non-Current Liabilities is $42000.0 (2022), against an average of $53375.0.
  • The widest annual swing landed in 2024, when Other Non-Current Liabilities sank 91.84%; it then soared 2300.0% in 2025.
  • Tracing ELMD's Other Non-Current Liabilities over 5 years: stood at $33000.0 in 2022, then soared by 48.48% to $49000.0 in 2023, then slumped by 91.84% to $4000.0 in 2024, then soared by 2300.0% to $96000.0 in 2025, then retreated by 15.62% to $81000.0 in 2026.
  • Per Business Quant, the three latest ELMD Other Non-Current Liabilities figures stand at $81000.0 (Q1 2026), $96000.0 (Q4 2025), and $110000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Electromed 300.53 Mn 283.55 Mn 14.64 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 81,000.00
Dec 31, 2025 96,000.00
Sep 30, 2025 110,000.00
Jun 30, 2025 125,000.00
Dec 31, 2024 4,000.00
Sep 30, 2024 8,000.00
Jun 30, 2024 12,000.00
Mar 31, 2024 31,000.00
Dec 31, 2023 49,000.00
Sep 30, 2023 68,000.00
Jun 30, 2023 86,000.00
Mar 31, 2023 30,000.00
Dec 31, 2022 33,000.00
Sep 30, 2022 37,000.00
Jun 30, 2022 41,000.00
Mar 31, 2022 43,000.00
Dec 31, 2021 47,000.00
Sep 30, 2021 50,000.00
Jun 30, 2021 54,000.00
Mar 31, 2021 59,702.00
Dec 31, 2020 3,929.00
Sep 30, 2020 6,001.00
Jun 30, 2020 9,000.00
Mar 31, 2020 24,324.00
Dec 31, 2019 39,628.00
Sep 30, 2019 55,269.00
Jun 30, 2019 14,737.00
Jun 30, 2018 14,737.00